SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000909661-03-000008
Filing Date
2003-02-10
Accepted
2003-02-10 16:22:24
Documents
1
Group Members
DAVID. I. COHENFARALLON CAPITAL INSTITUTIONAL PARTNERS II, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS III, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS, L.P.FARALLON CAPITAL PARTNERS, L.P.FARALLON PARTNERS, L.L.C.JOSEPH F. DOWNESMARK C. WEHRLYMONICA R. LA

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMENDMENT 1 amylin13g_a.txt SC 13G/A 62337
  Complete submission text file 0000909661-03-000008.txt   64982
Mailing Address 9373 TOWNE CENTRE DR SAN DIEGO CA 92121
Business Address 9373 TOWNE CENTRE DR SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Subject) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-42168 | Film No.: 03547602
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE MARITIME PLAZA SAN FRANCISCO CA 94111
Business Address ONE MARITIME PLAZA STE 11325 SAN FRANCISCO CA 94111 4154212132
FARALLON CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000909661 (see all company filings)

IRS No.: 943240279